衰弱与大泌尿肿瘤手术后更高的医疗资源利用相关
基于2012—2016年美国外科医师学会国家手术质量改进计划中92999例接受根治性膀胱切除、根治性前列腺切除、根治性肾切除或部分肾切除的患者,回顾性队列研究显示衰弱指数每增加一级,医疗资源利用(HRU)风险逐步升高,调整人口学后衰弱指数1、2、≥3相对无衰弱的OR分别为1.2、1.5、2.0(均p<0.001),并发症率亦随衰弱评分升高。
要点
- 衰弱评分每增加一级,HRU风险逐步升高,指数≥3时OR为2.0(95%CI 1.8-2.1;p<0.001)。
- 各手术类型中衰弱评分升高均与任何并发症及严重并发症发生率升高相关。
- 衰弱指数升高独立关联延长住院、转续医疗机构及30天内非计划再入院。
核心结论
- 大泌尿肿瘤手术中衰弱与更高的医疗资源利用和手术并发症相关。
研究设计与样本
- 回顾性队列研究,纳入2012—2016年美国外科医师学会国家手术质量改进计划中接受根治性膀胱切除或微创或开放根治性前列腺切除、根治性肾切除或部分肾切除的92999例受试者。
主要发现
- 在整体队列92999例及每种手术类型内,衰弱评分增加与HRU显著逐步增加相关。
- 调整人口学后,相对无衰弱,衰弱指数1、2、≥3的HRU比值比分别为1.2(95%CI 1.2-1.3;p<0.001)、1.5(95%CI 1.4-1.6;p<0.001)、2.0(95%CI 1.8-2.1;p<0.001)。
- 亚组分析中,衰弱指数每提升一个类别独立关联延长住院、更多转续医疗机构及非计划再入院。
- 每种手术类型内,衰弱评分增加与任何并发症及严重并发症发生率升高相关。
局限性
- 分析受限于回顾性设计及大型医院数据库内可获取的数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the setting of value-based care, it is critical to improve our understanding of surgical risk and greater health care resource utilization (HRU) as it relates to frailty. OBJECTIVE: To evaluate the impact of frailty on HRU and surgical morbidity in urologic oncology surgery using the five-item frailty index. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study was conducted using subjects from the 2012-2016 American College of Surgeons National Surgical Quality Improvement Program who underwent radical cystectomy or minimally invasive or open radical prostatectomy, radical nephrectomy, or partial nephrectomy. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Multivariable logistic regression was performed to determine the association between frailty index and any increase in HRU, which was defined as prolonged length of stay greater than the 75th percentile, discharge to continued care, or unplanned readmission within 30 d. RESULTS AND LIMITATIONS: In the overall cohort of 92 999 subjects and within each surgery type, increasing frailty score was associated with significant stepwise increases in HRU. Logistic regression adjusting for patient demographics revealed statistically significant odds ratios of 1.2 (95% confidence interval [CI] 1.2-1.3; p<0.001), 1.5 (95% CI 1.4-1.6; p<0.001), and 2.0 (95% CI 1.8-2.1; p<0.001) at frailty indices of 1, 2, and ≥3, respectively, for increased HRU relative to no frailty. In subanalyses, each categorical increase in frailty index was independently associated with prolonged length of stay, more discharges to continued care, and unplanned readmission. Increasing frailty score was associated with increasing rates of any complication and serious complications within each surgery type. The analysis is limited by the retrospective design and available data within a large hospital-based database. CONCLUSIONS: Frailty in major urologic oncology surgery is associated with greater HRU and surgical morbidity. PATIENT SUMMARY: We assessed the impact of frailty on greater health care resource utilization and complications after major urologic cancer surgery in a large US population. With each increase in a frailty score, there was an increase in the likelihood of having complications, prolonged hospital stay, more discharges to continued care, and unplanned readmissions within 30 d.
引用
- Taylor BL, Xia L, Guzzo TJ, et al. Frailty and Greater Health Care Resource Utilization Following Major Urologic Oncology Surgery. Eur Urol Oncol. 2018. PMID: 30929842. doi:10.1016/j.euo.2018.06.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。